Fauci adviser David Morens pleads guilty to avoiding records requests, conspiracy to defraud government
Morens said he had agreed to work to avoid public disclosures and to use his influence to advance a company's interests.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
Policy decisions in Washington and the states shape what Medicare covers and costs. These stories track the legislation, regulation, and politics behind the program.
STAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firm
Private equity firms have taken a strong interest in revenue cycle management firms, such as Ensemble.
Read full article →Trump administration sued over visa time limit that would affect grad students, postdocs
DHS was sued Tuesday over a sweeping policy change that would limit how long foreign students and scholars can remain in the U.S.
Read full article →STAT+: The White House declares ‘promises made, promises kept’ on lowering drug prices. Nice try
In its effort to lower drug prices, the White House has declared "promises made, promises kept." That's a narrative that doesn't reflect the full story.
Read full article →Are you scrolling, instead of sleeping again? Here's when it may be an addiction
Claims that Meta made its platforms addictive are now being tested in court. But what separates a bad scrolling habit from an addiction, and what can people do about it?
Read full article →STAT+: Real-world psilocybin data suggest need for close monitoring
Amylyx reports success in a pivotal trial, biopharma A-listers join a pain-blocking device company board, and more biotech news from The Readout
Read full article →STAT+: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024
Top executives of major health systems got substantial raises, even as their hospitals grappled with plenty of challenges.
Read full article →STAT+: Government workers feel the squeeze on health care
Municipalities are struggling with the cost of health insurance for their workers, and states are facing a major decision on Medicaid drug coverage.
Read full article →STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell short of its primary goal
Read full article →Kindergarten vaccine exemptions are climbing
Doritos as "real" "food," public-sector health care in trouble, and more health news from Morning Rounds
Read full article →STAT+: Prominent AI startup rolls out virtual cell model in race to speed up science
A prominent AI startup has rolled out a virtual cell model, advancing the race to speed up science.
Read full article →STAT+: Amylyx endocrine drug succeeds in pivotal study
In a Phase 3 trial of people with post-bariatric hypoglycemia, those taking the drug, avexitide, experienced a 55% reduction in the rate of serious low blood sugar events compared with…
Read full article →